These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. What can we learn from epigenetics in the year 2009? Jüngel A; Ospelt C; Gay S Curr Opin Rheumatol; 2010 May; 22(3):284-92. PubMed ID: 20305560 [TBL] [Abstract][Full Text] [Related]
4. New insights into the epigenetics of inflammatory rheumatic diseases. Ballestar E; Li T Nat Rev Rheumatol; 2017 Oct; 13(10):593-605. PubMed ID: 28905855 [TBL] [Abstract][Full Text] [Related]
10. Epigenetics for Clinicians from the Perspective of Pediatric Rheumatic Diseases. Akbaba TH; Sag E; Balci-Peynircioglu B; Ozen S Curr Rheumatol Rep; 2020 Jul; 22(8):46. PubMed ID: 32654092 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of autoimmune diseases: from bench to bedside. Picascia A; Grimaldi V; Pignalosa O; De Pascale MR; Schiano C; Napoli C Clin Immunol; 2015 Mar; 157(1):1-15. PubMed ID: 25576661 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic changes in status epilepticus. Henshall DC Epilepsia; 2018 Oct; 59 Suppl 2():82-86. PubMed ID: 30159897 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. Wilson AG J Periodontol; 2008 Aug; 79(8 Suppl):1514-9. PubMed ID: 18673005 [TBL] [Abstract][Full Text] [Related]
16. The Mechanisms Underlying Chronic Inflammation in Rheumatoid Arthritis from the Perspective of the Epigenetic Landscape. Araki Y; Mimura T J Immunol Res; 2016; 2016():6290682. PubMed ID: 28116320 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA epigenetic signatures in human disease. Piletič K; Kunej T Arch Toxicol; 2016 Oct; 90(10):2405-19. PubMed ID: 27557899 [TBL] [Abstract][Full Text] [Related]
18. Interplay between microRNAs and the epigenetic machinery: an intricate network. Iorio MV; Piovan C; Croce CM Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? Jeffries MA; Sawalha AH Expert Rev Clin Immunol; 2015 Jan; 11(1):45-58. PubMed ID: 25534978 [TBL] [Abstract][Full Text] [Related]
20. The potential of DNA modifications as biomarkers and therapeutic targets in oncology. Jankowska AM; Millward CL; Caldwell CW Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]